Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Subcutaneous Desferrioxamine in Transfusional Hemochromatosis
NCT00000595Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jan 1978
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of deferoxamine in Secondary hemochromatosis, sponsored by National Heart, Lung, and Blood Institute. Started Jan 1978; status: completed.
02
Drugs
deferoxamine
03
Conditions
Secondary hemochromatosis
Beyond the preview
Go deeper on NCT00000595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000595.